Véronique Miette

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

M. Sasso, Michel Beaugrand, Victor de Lédinghen et al. · Ultrasound in Medicine & Biology · 2010 · 837 citations

Medical Ultrasound, Hepatology, Power Ultrasound +10

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

Philip N. Newsome, M. Sasso, Jonathan J Deeks et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 729 citations · Full text

Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

Stephen A. Harrison, Samer Gawrieh, Katharine Roberts et al. · Journal of Hepatology · 2021 · 267 citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +12

Liver Stiffness Measurement in Children Using FibroScan: Feasibility Study and Comparison With Fibrotest, Aspartate Transaminase to Platelets Ratio Index, and Liver Biopsy

Victor de Lédinghen, Brigitte Le Bail, Laurent Rebouissoux et al. · Journal of Pediatric Gastroenterology and Nutrition · 2007 · 257 citations

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan^®: validation in chronic hepatitis C

M. Sasso, Iulia Tengher-Barna, Marianne Ziol et al. · Journal of Viral Hepatitis · 2011 · 214 citations